Showing results (1421-1430 of 1,838) with videos related to

Sort By:
Pageof 184
Journal of Medical Microbiology|May 13, 2005
Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infectionYoshifumi Imamura, Katsunori Yanagihara, Kazunori Tomono, et al.
Journal of Epidemiology|April 26, 2016
Underweight Young Women Without Later Weight Gain Are at High Risk for Osteopenia After Midlife: The KOBE StudyYukako Tatsumi, Aya Higashiyama, Yoshimi Kubota, et al.
Nutrients|May 25, 2024
Na and K Intake from Lunches Served in a Japanese Company Cafeteria and the Estimated Improvement in the Dietary Na/K Ratio Using Low-Na/K Seasonings and Dairy to Prevent HypertensionNagako Okuda, Aya Higashiyama, Kozo Tanno, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 2, 2017
Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular NeovascularizationYuki Inoue, Masamitsu Shimazawa, Shinsuke Nakamura, et al.
Plos One|May 10, 2017
Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinomaYoshinori Ohno, Mitsuhito Koizumi, Hironao Nakayama, et al.
Endocrine Journal|July 8, 1999
Contribution of a missense mutation (Trp64Arg) in beta3-adrenergic receptor gene to multiple risk factors in Japanese men with hyperuricemiaH Hayashi, S Nagasaka, S Ishikawa, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological studyRyu Kanzaki, Masahiko Higashiyama, Ayako Fujiwara, et al.
BMC Cancer|February 16, 2013
The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancerMasato Shingyoji, Toshihiko Iizasa, Masahiko Higashiyama, et al.
Endocrine Journal|May 29, 2008
Prevalence and prognosis of familial follicular thyroid carcinomaYasuhiro Ito, Mitsuhiro Fukushima, Tomonori Yabuta, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2020
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expressionKen Masuda, Hidehito Horinouchi, Midori Tanaka, et al.
Pageof 184